Another beneficial effect of rituximab on refractory ANCA-associated vasculitis: The role of interleukin-17 suppression?

S. J. Park; J. I. Shin

doi:10.1111/sji.12025

Another beneficial effect of rituximab on refractory ANCA-associated vasculitis: The role of interleukin-17 suppression?

S. J. Park, J. I. Shin

Department of Pediatrics

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	221
Number of pages	1
Journal	Scandinavian Journal of Immunology
Volume	77
Issue number	3
DOIs	https://doi.org/10.1111/sji.12025
Publication status	Published - 2013 Mar

All Science Journal Classification (ASJC) codes

Immunology

Access to Document

10.1111/sji.12025

Cite this

@article{5ffba444a6ce45bb9eeafda8349297e9,

title = "Another beneficial effect of rituximab on refractory ANCA-associated vasculitis: The role of interleukin-17 suppression?",

author = "Park, {S. J.} and Shin, {J. I.}",

year = "2013",

month = mar,

doi = "10.1111/sji.12025",

language = "English",

volume = "77",

pages = "221",

journal = "Scandinavian Journal of Immunology",

issn = "0300-9475",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Another beneficial effect of rituximab on refractory ANCA-associated vasculitis

T2 - The role of interleukin-17 suppression?

AU - Park, S. J.

AU - Shin, J. I.

PY - 2013/3

Y1 - 2013/3

UR - http://www.scopus.com/inward/record.url?scp=84875630906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875630906&partnerID=8YFLogxK

U2 - 10.1111/sji.12025

DO - 10.1111/sji.12025

M3 - Letter

C2 - 23298391

AN - SCOPUS:84875630906

SN - 0300-9475

VL - 77

SP - 221

JO - Scandinavian Journal of Immunology

JF - Scandinavian Journal of Immunology

IS - 3

ER -

Another beneficial effect of rituximab on refractory ANCA-associated vasculitis: The role of interleukin-17 suppression?

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this